Filing Details
- Accession Number:
- 0001493152-20-004749
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-25 21:05:23
- Reporting Period:
- 2020-03-23
- Accepted Time:
- 2020-03-25 21:05:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1076682 | Polarityte Inc. | PTE | Biological Products, (No Disgnostic Substances) (2836) | 061529524 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744816 | Elliot Paul Mann | 123 Wright Brothers Drive Salt Lake City UT 84116 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-03-23 | 1,283 | $1.05 | 439,111 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The reported sale was effectuated pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12,2019, as amended November 19, 2019. The sale is intended to cover withholding taxes resulting from vesting ofrestricted stock units that were previously reported on Table I.
Billionaire Hedge Funds
